In randomised trials, zinc taken once a common cold had started was associated with shorter colds, while zinc taken regularly showed little or no effect on how many colds occurred; non-serious side effects were more frequent with zinc.
Low certainty
Further research is likely to change this.Who this is about
children and adults with the common cold
Practical note
Graded low, matching the 2024 Cochrane review: duration was about 2.4 days shorter (8 trials, 972 participants) but with very high heterogeneity (I2 97 percent) and most trials at unclear or high risk of bias. Lozenge trials of zinc gluconate used 45 to 276 mg a day for 4.5 to 21 days.
Safety note
Treatment trials found more non-serious adverse events with zinc (moderate certainty); the review lists unpleasant taste, loss of smell, vomiting, stomach cramps and diarrhoea as possible zinc-related effects.
Sources
- Supports “The findings suggest that zinc supplementation may have little or no effect on the prevention of colds but may reduce the duration of ongoing colds, with an increase in non-serious adverse events.” (Abstract, conclusions) Nault D, Machingo TA, Shipper AG, Antiporta DA, Hamel C, Nourouzpour S, Konstantinidis M, Phillips E, Lipski EA, Wieland LS. 2024. Cochrane Database of Systematic Reviews. Zinc for prevention and treatment of the common cold. Copyright The Cochrane Collaboration, published by John Wiley and Sons; metadata and short quotes only; Courtesy of the U.S. National Library of Medicine
- Context “Zinc gluconate was given at doses between 45 and 276 mg/day for between 4.5 and 21 days.” (Abstract, main results) Nault D, Machingo TA, Shipper AG, Antiporta DA, Hamel C, Nourouzpour S, Konstantinidis M, Phillips E, Lipski EA, Wieland LS. 2024. Cochrane Database of Systematic Reviews. Zinc for prevention and treatment of the common cold. Copyright The Cochrane Collaboration, published by John Wiley and Sons; metadata and short quotes only; Courtesy of the U.S. National Library of Medicine